Omeros ROE 2010-2025 | OMER

Current and historical return on equity (ROE) values for Omeros (OMER) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Omeros ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.15B $-0.21B 89.94%
2024-12-31 $-0.16B $-0.18B 117.07%
2024-09-30 $-0.13B $-0.15B 142.93%
2024-06-30 $-0.14B $-0.13B 238.30%
2024-03-31 $-0.12B $-0.07B 543.82%
2023-12-31 $-0.12B $-0.03B -1275.68%
2023-09-30 $0.02B $-0.01B 54.05%
2023-06-30 $0.04B $0.02B 141.38%
2023-03-31 $0.05B $0.06B 303.23%
2022-12-31 $0.05B $0.09B 9600.00%
2022-09-30 $0.20B $-0.05B -1333.33%
2022-06-30 $0.19B $-0.03B -280.14%
2022-03-31 $0.20B $-0.01B -160.00%
2021-12-31 $0.19B $0.02B -109.76%
2021-09-30 $-0.12B $-0.26B 58.22%
2021-06-30 $-0.14B $-0.25B 82.25%
2021-03-31 $-0.14B $-0.22B 96.79%
2020-12-31 $-0.14B $-0.12B 109.38%
2020-09-30 $-0.13B $-0.09B 105.52%
2020-06-30 $-0.11B $-0.16B 78.97%
2020-03-31 $-0.09B $-0.13B 68.88%
2019-12-31 $-0.08B $-0.11B 66.40%
2019-09-30 $-0.08B $-0.14B 63.54%
2019-06-30 $-0.10B $-0.13B 91.82%
2019-03-31 $-0.12B $-0.12B 132.24%
2018-12-31 $-0.13B $-0.10B 185.40%
2018-09-30 $-0.12B $-0.09B 271.19%
2018-06-30 $-0.09B $-0.06B 445.57%
2018-03-31 $-0.07B $-0.03B 348.72%
2017-12-31 $-0.05B $0.00B 218.56%
2017-09-30 $-0.06B $0.01B 170.99%
2017-06-30 $-0.06B $-0.06B 154.60%
2017-03-31 $-0.06B $-0.05B 157.96%
2016-12-31 $-0.07B $-0.04B 181.33%
2016-09-30 $-0.07B $-0.02B 195.68%
2016-06-30 $-0.07B $-0.05B 236.80%
2016-03-31 $-0.08B $-0.04B 458.82%
2015-12-31 $-0.08B $-0.03B 6080.00%
2015-09-30 $-0.08B $-0.01B 1400.00%
2015-06-30 $-0.08B $0.01B 750.00%
2015-03-31 $-0.08B $0.02B 515.25%
2014-12-31 $-0.07B $-0.04B 389.47%
2014-09-30 $-0.06B $-0.03B 431.37%
2014-06-30 $-0.05B $-0.01B 425.00%
2014-03-31 $-0.05B $0.01B 383.67%
2013-12-31 $-0.04B $-0.02B 228.57%
2013-09-30 $-0.05B $-0.02B 311.86%
2013-06-30 $-0.05B $-0.01B 500.00%
2013-03-31 $-0.04B $-0.02B 355.56%
2012-12-31 $-0.04B $-0.01B 371.43%
2012-09-30 $-0.04B $0.00B 400.00%
2012-06-30 $-0.04B $-0.02B 388.89%
2012-03-31 $-0.03B $-0.01B 2480.00%
2011-12-31 $-0.03B $-0.01B -504.35%
2011-09-30 $-0.03B $0.00B -212.24%
2011-06-30 $-0.03B $0.01B -158.82%
2011-03-31 $-0.03B $0.02B -136.36%
2010-12-31 $-0.03B $0.02B -109.09%
2010-09-30 $-0.03B $0.02B -87.22%
2010-06-30 $-0.03B $0.03B -104.17%
2010-03-31 $-0.02B $0.04B -139.39%
2009-12-31 $-0.02B $0.04B -289.66%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.188B $0.000B
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.381B 27.82
Boston Scientific (BSX) United States $149.868B 37.52
Stryker (SYK) United States $143.347B 29.97
EssilorLuxottica (ESLOY) France $128.152B 0.00
Medtronic (MDT) Ireland $110.735B 15.70
Lonza Group Ag (LZAGY) Switzerland $49.273B 0.00
Haleon (HLN) United Kingdom $46.835B 26.69
ResMed (RMD) United States $37.196B 27.94
Agilent Technologies (A) United States $32.827B 21.40
GE HealthCare Technologies (GEHC) United States $32.638B 15.50
Terumo (TRUMY) Japan $26.398B 34.29
Koninklijke Philips (PHG) Netherlands $21.463B 15.06
Insulet (PODD) United States $21.334B 83.74
Zimmer Biomet Holdings (ZBH) United States $18.048B 11.59
Baxter (BAX) United States $15.390B 11.49
Smith & Nephew SNATS (SNN) United Kingdom $12.627B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.442B 22.42
Lantheus Holdings (LNTH) United States $5.479B 13.82
Prestige Consumer Healthcare (PBH) United States $4.123B 18.42
Perrigo (PRGO) Ireland $3.643B 9.23
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.415B 15.55
Envista Holdings (NVST) United States $3.202B 26.61
ICU Medical (ICUI) United States $3.144B 23.18
QuidelOrtho (QDEL) United States $1.896B 13.04
LeMaitre Vascular (LMAT) United States $1.848B 41.30
AtriCure (ATRC) United States $1.554B 0.00
Acuren (TIC) United States $1.324B 0.00
AdaptHealth (AHCO) United States $1.132B 11.49
Neogen (NEOG) United States $1.072B 13.72
Green Thumb Industries (GTBIF) United States $1.042B 23.43
BioLife Solutions (BLFS) United States $1.008B 0.00
Phibro Animal Health (PAHC) United States $0.968B 12.37
InMode (INMD) Israel $0.839B 8.46
Kestra Medical Technologies (KMTS) United States $0.772B 0.00
CeriBell (CBLL) United States $0.647B 0.00
Evolus (EOLS) United States $0.598B 0.00
Owens & Minor (OMI) United States $0.567B 4.71
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.525B 0.00
Valneva SE (VALN) France $0.478B 0.00
Surmodics (SRDX) United States $0.415B 0.00
Capricor Therapeutics (CAPR) United States $0.377B 0.00
Tilray Brands (TLRY) Canada $0.362B 0.00
SNDL (SNDL) Canada $0.328B 0.00
VAREX IMAGING (VREX) United States $0.319B 11.74
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.288B 0.00
Viemed Healthcare (VMD) United States $0.262B 22.07
Cerus (CERS) United States $0.256B 0.00
ZimVie (ZIMV) United States $0.245B 11.13
Sanara MedTech (SMTI) United States $0.242B 0.00
Quanterix (QTRX) United States $0.238B 0.00
Aurora Cannabis (ACB) Canada $0.229B 68.00
Canopy Growth (CGC) Canada $0.228B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Biote (BTMD) United States $0.217B 6.09
Cresco Labs (CRLBF) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
Brainsway (BWAY) Israel $0.206B 54.55
High Tide (HITI) Canada $0.180B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.19
Verano Holdings (VRNOF) United States $0.174B 0.00
Organigram Global (OGI) Canada $0.173B 0.00
Exagen (XGN) United States $0.154B 0.00
Vireo Growth (VREOF) United States $0.132B 0.00
FitLife Brands (FTLF) United States $0.125B 15.40
Jin Medical (ZJYL) China $0.095B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.088B 11.34
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
MacroGenics (MGNX) United States $0.083B 0.00
Agape ATP (ATPC) $0.079B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Apyx Medical (APYX) United States $0.076B 0.00
Zynex (ZYXI) United States $0.075B 0.00
Cytosorbents (CTSO) United States $0.074B 0.00
InterCure (INCR) Israel $0.069B 0.00
ImmuCell (ICCC) United States $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Nephros (NEPH) United States $0.053B 71.43
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 12.98
Rockwell Medical (RMTI) United States $0.030B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
INLIF (INLF) $0.019B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00